Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Association between Paget's disease and primary hyperparathyroidism]

M A Sarli1, R Spivacow, S Morillo

  • 1Instituto de Investigaciones Metabólicas, Buenos Aires, Argentina.

Medicina
|January 1, 1997
PubMed
Summary

The association between primary hyperparathyroidism and Paget's disease of bone is rare. This study identified 5 new cases, highlighting diagnostic clues and treatment approaches for this uncommon comorbidity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Retreatment with teriparatide: our experience in three patients with severe secondary osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis.

Journal of osteoporosis·2016
Same author

Bone microarchitecture in Rett syndrome and treatment with teriparatide: a case report.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Rare Diseases

Context:

  • Primary hyperparathyroidism and Paget's disease of bone are common endocrine and bone disorders, respectively.
  • Their co-occurrence is exceptionally rare, with unknown underlying mechanisms.
  • Parathyroid function significantly impacts Paget's disease, and vice versa.

Purpose:

  • To investigate the association between primary hyperparathyroidism and Paget's disease of bone.
  • To identify diagnostic indicators and management strategies for patients with both conditions.
  • To compare findings with previously reported cases.

Summary:

  • A 10-year study reviewed 175 Paget's disease patients and 60 primary hyperparathyroidism patients, identifying 5 cases of co-association.

Related Experiment Videos

  • Diagnostic clues included hypercalcemia in Paget's patients and elevated alkaline phosphatase post-parathyroid surgery.
  • Treatment involved surgery for 3 patients and antiresorptive drugs for others.

    • Impact:

    • This research sheds light on the rare co-occurrence of primary hyperparathyroidism and Paget's disease.
    • It provides valuable insights into diagnostic challenges and therapeutic options.
    • The findings contribute to a better understanding of the complex interplay between these two bone disorders.